Over its history, the University of Maryland Heart Transplant Program has maintained excellent outcomes despite a modest overall level of activity.
Over the past 7 years, since February of 1996, 40 transplants have been performed in 39 patients, with 30-day patient survival of 95%. Two-month and one-year survival has been 84%, two-year survival 80%, and three year survival 75%.
As shown in the graph (below), University of Maryland heart transplant survival outcomes (green line) compare favorably with contemporary International Society for Heart and Lung Transplant (ISHLT) outcome benchmarks (yellow, red lines).
Between February 2002 and December 2002, 14 heart transplants were performed at University of Maryland, under the care of the current team of medical, surgical, and nursing personnel. Actual patient survivals are 100% at one, two, and six months after transplant. At the time of this writing (January 2003), all patients are currently stable as outpatients, and are safely beyond the dangerous early post-operative period.
Early outcomes for this group of patients are reflected in the purple dashed line in the graph.